Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, semaglutide can make you vomit. Vomiting is one of the most commonly reported side effects of semaglutide-based treatments like Wegovy, particularly in the first few weeks or after a dose increase. Most people who experience it find it settles as the body adjusts — but there are steps that genuinely help, and a handful of signs that mean it is time to call a doctor. These are prescription-only medicines, and whether semaglutide is right for you is a decision made with a prescriber who can weigh up your full health picture before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works partly by slowing gastric emptying, the rate at which food moves from the stomach into the small intestine. That slowing is useful for appetite regulation, but it also means the stomach can feel fuller for longer than it used to, and that fullness can tip into nausea or, for some people, vomiting. The underlying mechanism involves GLP-1 receptors in the gut as well as in the brain's appetite centres, and the combined signal can feel quite forceful when the medicine is new to your system.
Dose increases tend to be the flashpoint. The standard titration schedule starts at a low dose precisely to let your body acclimatise before the therapeutic dose is reached, jumping straight to a higher dose would make GI side effects far more likely. Even so, each step up carries a fresh adjustment period, and vomiting during those first few days is not unusual. The NHS semaglutide medicines page lists vomiting as a very common side effect, meaning it affects more than one in ten people at some point during treatment.
Eating habits matter a great deal here. Large meals, fatty foods, and eating quickly all increase the likelihood of vomiting because they add volume and slowed digestion on top of an already-slowed stomach. Small, lower-fat meals eaten slowly give the stomach the best chance of coping. It is one of those practical adjustments that sounds simple but makes a measurable difference, a useful one-minute habit is to look at your plate before eating and ask whether the portion is genuinely smaller than it would have been before treatment started. If it is not, halving it is a reasonable starting point.
The active ingredient is the same across semaglutide-based products, so the vomiting risk is broadly similar. The question people most often mean is whether the higher doses used in weight management (up to 2.4mg weekly with Wegovy's licensed schedule) carry more GI burden than lower doses used in diabetes treatment. They can, because the dose is higher, but the titration period is designed to manage that. In clinical trials of semaglutide 2.4mg, nausea and vomiting were reported most often in the early months and reduced substantially over time for most participants.
If you are wondering whether Wegovy specifically makes you vomit or whether what you are experiencing is typical, the short answer is: yes, Wegovy can cause vomiting, the pattern is well-documented, and the titration schedule exists to limit it. Some people sail through with minimal nausea; others find the first few weeks genuinely uncomfortable. Both outcomes are within the normal range. A related concern many patients raise is persistent nausea without actually being sick, that is equally common and similarly tied to dose timing and food choices.
Fatigue sometimes accompanies GI upset on semaglutide, which can compound the feeling of being unwell. If tiredness is adding to the picture, it is worth reading about semaglutide-related fatigue separately, as the causes overlap only partially.
Most vomiting on semaglutide is self-limiting, it passes within a day or two, particularly if you adjust your eating pattern. The situations where it stops being a manageable side effect and becomes a clinical concern are worth knowing clearly.
Seek prompt medical help if you cannot keep fluids down for more than 24 hours, because dehydration can put strain on the kidneys, and people on semaglutide who become severely dehydrated are at higher risk of acute kidney injury. Seek urgent help if vomiting is accompanied by severe, persistent abdominal pain that radiates toward the back, this combination can be a sign of pancreatitis, which the MHRA has highlighted as an infrequent but serious risk with GLP-1 medicines. Similarly, if you notice blood in vomit, or if vomiting is so frequent that you are losing significant weight beyond what treatment would explain, contact your prescriber or go to urgent care.
A detailed account of how to manage vomiting episodes on Wegovy covers practical recovery steps. Beyond those immediate actions, your prescriber can discuss whether slowing the titration pace or adjusting injection timing might reduce the frequency. That conversation is best had before abandoning treatment entirely, because many people who struggle early on find a rhythm that works. You can also report any side effect you suspect is linked to semaglutide through the MHRA's Yellow Card scheme, patient reports genuinely inform ongoing safety monitoring.
Vomiting that is frequent, distressing, or affecting your ability to stay hydrated is not something to push through alone. A prescriber can review whether the titration schedule suits your individual tolerance, whether the timing of your injection is contributing (some people find switching injection day or time of day helps), and whether any other medicines you take might be interacting with semaglutide's effect on gastric motility. Anti-nausea medicines are sometimes appropriate in the short term, but that is a clinical decision, not a self-prescribing one.
At nume, side effects are part of every consultation, our prescribers discuss what to expect and what to watch for before treatment is approved, and aftercare is available seven days a week if something changes once you have started. Semaglutide is a prescription-only medicine and clinical assessment covers exactly these scenarios. You can also read a broader overview of weight-loss treatment options if you are still deciding which approach fits your circumstances. If you are already on treatment and would like clinical input, speak to our prescribers, no question about a side effect is too minor to raise.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.